Addictions Department,Institute of Psychiatry,Psychology and Neuroscience,King's College London,London,England.
Social Genetic and Developmental Psychiatry Centre,Institute of Psychiatry,Psychology and Neuroscience,King's College London,London,England.
Psychol Med. 2018 Dec;48(16):2786-2793. doi: 10.1017/S0033291718000478. Epub 2018 Mar 13.
The genetic component of Cannabis Use Disorder may overlap with influences acting more generally on early stages of cannabis use. This paper aims to determine the extent to which genetic influences on the development of cannabis abuse/dependence are correlated with those acting on the opportunity to use cannabis and frequency of use.
A cross-sectional study of 3303 Australian twins, measuring age of onset of cannabis use opportunity, lifetime frequency of cannabis use, and lifetime DSM-IV cannabis abuse/dependence. A trivariate Cholesky decomposition estimated additive genetic (A), shared environment (C) and unique environment (E) contributions to the opportunity to use cannabis, the frequency of cannabis use, cannabis abuse/dependence, and the extent of overlap between genetic and environmental factors associated with each phenotype.
Variance components estimates were A = 0.64 [95% confidence interval (CI) 0.58-0.70] and E = 0.36 (95% CI 0.29-0.42) for age of opportunity to use cannabis, A = 0.74 (95% CI 0.66-0.80) and E = 0.26 (95% CI 0.20-0.34) for cannabis use frequency, and A = 0.78 (95% CI 0.65-0.88) and E = 0.22 (95% CI 0.12-0.35) for cannabis abuse/dependence. Opportunity shares 45% of genetic influences with the frequency of use, and only 17% of additive genetic influences are unique to abuse/dependence from those acting on opportunity and frequency.
There are significant genetic contributions to lifetime cannabis abuse/dependence, but a large proportion of this overlaps with influences acting on opportunity and frequency of use. Individuals without drug use opportunity are uninformative, and studies of drug use disorders must incorporate individual exposure to accurately identify aetiology.
大麻使用障碍的遗传成分可能与更普遍影响大麻使用早期阶段的因素重叠。本文旨在确定对大麻滥用/依赖发展的遗传影响与对使用大麻机会和使用频率的影响之间的相关性程度。
对 3303 名澳大利亚双胞胎进行横断面研究,测量大麻使用机会的发病年龄、终生大麻使用频率以及 DSM-IV 大麻滥用/依赖的终生情况。三变量 Cholesky 分解估计了与使用大麻机会、大麻使用频率、大麻滥用/依赖以及与每种表型相关的遗传和环境因素之间重叠程度相关的可加遗传(A)、共享环境(C)和独特环境(E)的贡献。
年龄机会的方差分量估计值为 A = 0.64 [95%置信区间(CI)0.58-0.70]和 E = 0.36(95% CI 0.29-0.42),大麻使用频率的 A = 0.74(95% CI 0.66-0.80)和 E = 0.26(95% CI 0.20-0.34),大麻滥用/依赖的 A = 0.78(95% CI 0.65-0.88)和 E = 0.22(95% CI 0.12-0.35)。机会与使用频率共享 45%的遗传影响,只有 17%的可加遗传影响是滥用/依赖特有的,而不是作用于机会和频率的遗传影响。
终生大麻滥用/依赖有显著的遗传贡献,但很大一部分与对使用机会和使用频率的影响重叠。没有药物使用机会的个体没有信息,因此必须将个体暴露纳入药物使用障碍的研究中以准确确定病因。